Fort Washington Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Fort Washington Investment Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,856	Closed	-$218K	–	440
2022 Q1	$218K	Buy	+1,856	New	+$208K	﹤0.01%	497
2021 Q3	–	Sell	-9,797	Closed	-$1.01M	–	510
2021 Q2	$1.01M	Hold	9,797	–	–	0.01%	317
2021 Q1	$819K	Hold	9,797	–	–	0.01%	331
2020 Q4	$894K	Hold	9,797	–	–	0.01%	321
2020 Q3	$782K	Sell	9,797 -6,834	-41%	-$533K	0.01%	330
2020 Q2	$1.15M	Buy	+16,631	New	+$1.18M	0.01%	296

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fort Washington Investment Advisors's EW Position: Q2 2022 in Review

Fort Washington Investment Advisors sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 1,856 shares — an estimated $218K sold.

Fort Washington Investment Advisors first reported a position in EW in Q2 2020 and held it in 6 quarters. The position peaked at $1.15M in Q2 2020. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

Fort Washington Investment Advisors reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
Fort Washington Investment Advisors sold 1,856 Edwards Lifesciences shares in Q2 2022, an estimated $218K.
Fort Washington Investment Advisors first reported a position in Edwards Lifesciences in Q2 2020 and held it in 6 quarters.
Fort Washington Investment Advisors's Edwards Lifesciences position peaked at $1.15M in Q2 2020.
1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.